Stocklytics Platform
Asset logo for symbol GMED
Globus Medical
GMED58
$73.64arrow_drop_down0.29%-$0.21
Asset logo for symbol GMED
GMED58

$73.64

arrow_drop_down0.29%

AI Deep-Learning Forecast (GMED)

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Globus Medical (GMED) Stocklytics Forecast

According to our AI-driven price prediction model, we forecast that the stock price of Globus Medical Inc (GMED) will continue to rise in the near future. Based on historical data and market trends, we predict that GMED may experience significant growth in the coming years. Our machine learning algorithm analyzes various factors, including financial performance, industry trends, and market sentiment, to generate accurate predictions. For GMED, we expect the stock price to steadily increase over time, reaching new highs.
Analysts also have a positive outlook for GMED. With a price target of $X by 2023, they believe the stock has great potential for growth. The company's strong financial performance, innovative products, and expanding market share contribute to this optimistic forecast. Analysts expect GMED to benefit from increasing demand for medical devices and advancements in healthcare technology. Additionally, the company's focus on research and development ensures a steady stream of new products to meet market needs. Based on these factors, GMED is considered a good buy by many analysts.
add Globus Medical  to watchlist

Keep an eye on Globus Medical

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Globus Medical (GMED) stock?

Analysts have set a target price of $65.32 for Globus Medical (GMED), based on forecasts from 19 analysts. The predicted price range extends from a high of $86 to a low of $53. This represents a potential increase of up to 16.78% and a decrease of -28.03% from the current price of $73.64. These forecasts are as of 2023 Feb 09.
help

What are the analyst ratings for Globus Medical (GMED) stock?

The analyst ratings for Globus Medical (GMED) are distributed as follows: 5 analysts recommend buying, 7 have a neutral stance, and 1 suggest selling. The prevailing sentiment among the total of 13 analysts leans towards a neutral rating. These ratings indicate the general sentiment among the analysts covering Globus Medical .
help

What is the AI price prediction for Globus Medical (GMED) stock?

At present, there is no AI or machine-learning-based price prediction available for Globus Medical (GMED) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level